NEW YORK (

TheStreet

) --

CHANGE IN RATINGS

Biomarin

(BMRN) - Get Report

downgraded at Deutsche from Buy to Hold, Deutsche Bank said. Risk/reward is no longer compelling at current levels. $45 price target.

Energy Partners

(BKEP) - Get Report

downgraded to sell at TheStreet Ratings.

Chiquita Brands

(CQB)

downgraded to sell at TheStreet Ratings.

Globus Medical

(GMED) - Get Report

rated new Outperform at William Blair. Company can gain market share and deliver above-average annual sales growth.

LyondellBasell

(LYB) - Get Report

downgraded at UBS from Buy to Neutral, UBS said. $49 price target. Company could be hurt by rising ethane prices.

Public Service

(PEG) - Get Report

downgraded at FBR to Underperform, FBR Capital Markets said. Valuation call, based on a $30 price target.

Treehouse

(THS) - Get Report

upgraded at Citigroup from Neutral to Buy, Citigroup said. $61 price target. Estimates also boosted, ahead of the private-label K-Cup launch.

Westlake Chemical

(WLK) - Get Report

downgraded at UBS from Neutral to Sell, UBS said. Valuation call, based on a $54 price target.

Weyerhaeuser

(WY) - Get Report

upgraded at BMO from Underperform to Market Perform, BMO Capital said. Company is leveraged to rising lumber and panel prices. $26.50 price target.

STOCK COMMENTS / EPS CHANGES

Apple

(AAPL) - Get Report

target raised at Oppenheimer to $800, according to Oppenheimer. Expect higher mini-iPad and iPhone sales. Outperform rating.

Advanced Micro

(AMD) - Get Report

numbers reduced at Sterne Agee. Shares of AMD now seen reaching $6, according to Sterne Agee. Estimates also cut, given weaker consumer demand. Neutral rating.

Groupon

(GRPN) - Get Report

target reduced at Ascendiant to $3.50. Growth uncertainties and concerns remain. Sell rating.

Intel

(INTC) - Get Report

estimates reduced at JMP through 2013, JMP Securities said. Industry checks suggest weaker PC demand. Outperform rating and $33 price target.

Intel estimates, target cut at Citigroup. INTC estimates were reduced through 2013, Citigroup said. Company is likely to fall short of near-term earnings expectations. Buy rating and new $32 price target.

>To submit a news tip, email:

tips@thestreet.com

.

READERS ALSO LIKE:

>>Goldman Sachs Readies Bayou Battle

>>Stop Dumping on Facebook -- Hate Wall Street!

Follow

TheStreet

on

Twitter

and become a fan on

Facebook.

This article was written by a staff member of TheStreet.